glp 1 agonist liraglutide GLP-1 agonists have transformed diabetes and obesity care — but their soaring costs have created an affordability crisis for patients and our health care system Bestsellers_Bestsellers Purchase Plan:3-Months Supply Role of DPP-4 Inhibitors

glp 1 agonist liraglutide GLP-1 agonists have transformed diabetes and obesity care — but their soaring costs have created an affordability crisis for patients and our health care system Bestsellers_Bestsellers Purchase Plan:3-Months Supply Role of DPP-4 Inhibitors

Role of DPP-4 Inhibitors in Clinical Practice

The green list includes active pharmaceutical ingredients (APIs) in the GLP-1 drugs that have been inspected by the FDA and are determined to be in compliance with FDA standards

Bestsellers_Bestsellers

Purchase Plan:3-Months Supply

Sodium-glucose transporters (SGLT)-inhibitors The treatment of T2DM with glyflozines, sodium-glucose co-transporter 2 inhibitors, represents a new therapeutic approach ( Among SGLT2 inhibitors, three of them have been approved by the FDA and EMA: canagliflozin (2013), dapagliflozin (2014) and empagliflozin (2014)